Status:

COMPLETED

Hemopatch Performance Evaluation: A Prospective Observational Registry

Lead Sponsor:

Baxter Healthcare Corporation

Conditions:

Dura Mater Nick Cut or Tear

Hemostatis

Eligibility:

All Genders

Brief Summary

To assess the clinical performance and safety of HEMOPATCH Sealing Hemostat in a post-marketing setting in cardiovascular, thoracic, urologic, neurological, and other general surgical procedures.

Eligibility Criteria

Inclusion

  • Male or female patients of any age
  • Patients who had undergone open or minimal invasive surgical (MIS) procedures requiring the use of a patch to achieve dura repair, hemostasis, or control of leakage of air or other body fluid when pressure, ligature or other conventional procedures had been ineffective or impractical and where use of hemopatch was deemed appropriate by the surgeon according to its IFU in the following organ systems:
  • Hepato-biliary (liver, pancreas, gallbladder)
  • General surgery (in thyroid and other regions)
  • Cardiovascular (heart and vessels)
  • thoracic (lung and mediastinum)
  • Urological (kidney, prostate, and bladder
  • Neurological (dura mater, brain and spinal cord)
  • Provision of written informed consent/assent, as applicable, up to 72 hours after the date of surgery

Exclusion

  • Patients with known hypersensitivity to bovine proteins or brilliant blue
  • Patients who had intraoperative pulsatile or severe bleeding at the target application site (TAS)
  • Patients who had an active infection at the TAS

Key Trial Info

Start Date :

November 29 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 28 2019

Estimated Enrollment :

621 Patients enrolled

Trial Details

Trial ID

NCT03392662

Start Date

November 29 2017

End Date

January 28 2019

Last Update

November 16 2022

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Innsbruck Universitaetsklinik

Innsbruck, Austria, 6020

2

Fakultní nemocnice u sv. Anny v Brně

Brno, Czechia, 65691

3

Krajská Nemocnice Liberec

Liberec, Czechia, 46063

4

Fakultní Nemocnice Ostrava

Ostrava, Czechia, 70852

Hemopatch Performance Evaluation: A Prospective Observational Registry | DecenTrialz